-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Pear Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from Q1 2021 to Q4 2022.
- Pear Therapeutics, Inc. Depreciation for the quarter ending December 31, 2022 was $928K, a 41.2% increase year-over-year.
- Pear Therapeutics, Inc. Depreciation for the twelve months ending December 31, 2022 was $3.35M, a 98.2% increase year-over-year.
- Pear Therapeutics, Inc. annual Depreciation for 2022 was $3.35M, a 98.2% increase from 2021.
- Pear Therapeutics, Inc. annual Depreciation for 2021 was $1.69M, a 343% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)